Avricore Health Inc. AVCRF Archives - Page 5 of 6

MondayAug 16, 2021 10:52 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Signs First Amendment to its Agreement with Canada’s Abbott; Partners with Ellerca Health Inc. For Joint Diabetes Screening and Management Support, and Announces Systems Deployment to Select Shoppers Drug Mart(R) Locations

Avricore, through its subsidiary HealthTab(TM), will now distribute Abbott’s ID Now(TM) molecular testing device following the first amendment to the supplier distribution agreement between the two companies This amendment will allow for an improvement in onsite testing and reporting capabilities for SARS-CoV-2, along with RSV, Influenza A & B and Strep Avricore also announced its partnership with Ellerca Health Inc., in a move to utilize Ellerca’s technologies and service while focusing on diabetes screening and management Avricore also marked a huge milestone with the HealthTab(TM) system's deployment in specific Shoppers Drug Mart(R) locations On July 26, 2021, Avricore Health (TSX.V:…

TuesdayAug 10, 2021 10:05 am

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Announces Deployment of HealthTab(TM) Platform, Patient Testing in Select Shoppers Drug Mart(R) Locations

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) today announced that patient testing has begun on the HealthTab(TM) platform in select Shoppers Drug Mart(R) pharmacies. According to the update, participating Shoppers Drug Mart(R) pharmacies have now received their HealthTab(TM) systems and will begin offering screening tests to patients already identified as diabetics or with known conditions associated with pre-diabetes to provide diagnostic support and pharmacist-led consultation services. "We are very excited to pilot point-of-care testing with HealthTab and the Afinion 2 analyzer at select Shoppers Drug Mart(R) pharmacies,” said Frank Hack, director of Complex Care at Shoppers Drug Mart. “We are committed…

MondayAug 09, 2021 1:57 pm

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Rolling out Rapid Disease Testing in Canada, Plans to Expand into US and UK Markets

Avricore Health has announced that it is ready to roll out its HealthTab rapid disease testing system in pharmacies across Canada The rapid disease testing system comprises two key components, Avricore’s web-based HealthTab and Abbott’s Affinion 2 multi-assay analyzer The global point-of-care diagnostics market was valued at $34.49 billion in 2020 and is expected to continue growing and reach $81.37 billion by 2028 Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), an innovator in pharmacy services focused on the acquisition and development of early-stage technology aimed to move pharmacies forward, is set to roll out its proprietary HealthTab rapid disease testing system…

WednesdayAug 04, 2021 3:07 pm

QualityStocksNewsBreaks – Why Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Is ‘One to Watch’

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is focused on acquiring and developing emerging technologies aimed at innovating and moving pharmacy forward. The company intends to leverage its wholly owned subsidiary, HealthTab(TM), to create the largest global network of rapid testing devices in community pharmacies. “The HealthTab network model is unlike anything in pharmacy today. It gives knowledgeable and trusted pharmacists a greater role in primary care delivery and empowers patients to take more control of their health,” reads a recent article discussing Avricore’s flagship offering. “It also reduces costs and waiting times while providing many potential revenue streams, including equipment…

MondayAug 02, 2021 9:00 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Expands Testing Capabilities by Signing First Amendment to Abbott Distribution Agreement; Partners with Ellerca Health Inc to Support Patients’ Needs

Avricore Health signed the first amendment to its supplier distribution agreement between subsidiary HealthTab and Abbott The amendment adds to the agreement Abbott’s ID Now(TM) molecular testing device, which will bring in onsite testing and reporting capabilities for SARS-CoV-2 (Covid-19), RSV, Influenza A & B, and Strep Avricore also announced its partnership with Ellerca Health, which will see the companies use their respective technologies (Avricore’s HealthTab and Ellerca’s 360Care app) to support patient needs at community pharmacy level Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) recently made several key strides in its quest to become the world’s leader point-of-care technologies within…

ThursdayJul 29, 2021 3:56 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Featured on ‘PBA à Noon’ Podcast

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) was featured in a recent episode of the “PBA à Noon” podcast hosted by Paul Benwell & Associates. Avricore Health’s CEO Hector Bremner joined the program to discuss the company’s point-of-care testing platform, HealthTab(TM), which it recently launched in the first of 11 Shoppers Drug Mart pilot locations. The program’s initial focus is to screen patients at risk for diabetes and cardiovascular disease, as well as to support already diagnosed patients in better managing their conditions for a higher quality of life. “HealthTab is our flagship product at Avricore Health,” Bremner said, discussing the company’s…

WednesdayJul 28, 2021 2:23 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTC: AVCRF) Partners with Ellerca Health to Provide Enhanced Diabetes Screening, Management Support

Avricore Health (TSX.V: AVCR) (OTC: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward, has signed a partnership agreement with Ellerca Health Corp. The partnership is designed to leverage the two companies’ respective technologies and services in order to provide the most compelling diabetes screening and management solutions available for community pharmacy. Avricore’s focus is to make actionable health information more available by creating the largest rapid-testing network in pharmacy through its proprietary HealthTab(TM), a turnkey point-of-care testing solution that enables pharmacies to operate as diagnostic hubs, or community diagnostic centers, that connects them…

MondayJul 26, 2021 10:29 am

QualityStocksNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) HealthTab(TM) Adds ID Now(TM) Molecular Test Device to Abbott Distribution Agreement

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) today announced the signing of the first amendment to its supplier distribution agreement between HealthTab(TM) Inc., a wholly owned subsidiary, and Abbott, a global health care company and diagnostics leader in Canada. According to the update, the agreement, first signed on May 31, 2021, allows HealthTab(TM) to distribute in Canada Abbott’s Afinion(TM) 2, as well as associated tests for diabetes and heart-disease screening in community pharmacies. This includes HbA1c testing, which lead to the subsequent signing of a master agreement with Shoppers Drug Mart to bring this new testing to select locations as an…

MondayJul 26, 2021 9:30 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Completes Successful Trial Rollout and Expansion of Pharmacy Diagnostic Network

Avricore Health is an innovator in pharmacy based point-of-care diagnostics The company introduced its flagship technology platform in an Ontario Shoppers Drug Mart pharmacy earlier this month as the lead-out to a 12-store rollout throughout the province Avricore’s trademarked HealthTab network is making diagnostic tools for diabetes and cardiovascular disease management accessible to patients and the Shoppers Drug Mart agreement provides community locations as well as pharmacist support The trial rollout showed successful use by over 90 patients during a week-and-a-half period with seamless pharmacist personnel assistance for more than 600 test results Financing programs in January and February helped…

MondayJul 19, 2021 12:19 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Announces Successful Beta Testing of HealthTab(TM)

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) today announced that patient testing has begun on the first deployment of the new HealthTab(TM)-integrated Afinion 2(TM) analyzers in the initial Shoppers Drug Mart(R) pharmacy location. This move is part of the company’s previously announced effort to screen for diabetes and cardiovascular disease, demonstrating strong demand, smooth workflow and reliable system operations. To prepare for the full public launch, a first store was selected to receive the system to begin beta-testing HealthTab(TM)’s systems, including the first patient tests. HealthTab(TM) and the instruments are performing well, demonstrating that the first installation of HealthTab(TM) with the Afinion…

Site Search

Company Search

Tag: Avricore Health Inc. AVCRF